1. Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study. (27th August 2021) Authors: Khoo, Saye H; Fitzgerald, Richard; Fletcher, Thomas; Ewings, Sean; Jaki, Thomas; Lyon, Rebecca; Downs, Nichola; Walker, Lauren; Tansley-Hancock, Olana; Greenhalf, William; Woods, Christie; Reynolds, Helen; Marwood, Ellice; Mozgunov, Pavel; Adams, Emily; Bullock, Katie; Holman, Wayne; Bula, Marcin... Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 12(2021) Page Start: 3286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID). Issue 3 (20th January 2021) Authors: Crabb, Simon J.; Griffiths, Gareth; Marwood, Ellice; Dunkley, Denise; Downs, Nichola; Martin, Karen; Light, Michelle; Northey, Josh; Wilding, Sam; Whitehead, Amy; Shaw, Emily; Birtle, Alison J.; Bahl, Amit; Elliott, Tony; Westbury, Charlotte; Sundar, Santhanam; Robinson, Angus; Jagdev, Satinder; ... Journal: Journal of clinical oncology Issue: Volume 39:Issue 3(2021) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗